NYSE: FDS
Factset Research Systems Inc Stock

$456.09-3.30 (-0.72%)
Updated Feb 14, 2025
FDS Price
$456.09
Fair Value Price
N/A
Market Cap
$17.35B
52 Week Low
$391.84
52 Week High
$499.87
P/E
32.23x
P/B
8.71x
P/S
8.36x
PEG
2.49x
Dividend Yield
0.67%
Revenue
$2.23B
Earnings
$538.59M
Gross Margin
54.3%
Operating Margin
32.27%
Profit Margin
24.2%
Debt to Equity
1.03
Operating Cash Flow
$632M
Beta
0.9
Next Earnings
Mar 19, 2025
Ex-Dividend
N/A
Next Dividend
N/A

FDS Overview

FactSet Research Systems Inc. is a financial data and software company. FactSet provides client support & learning, implementation services, business advisory, data delivery, index services, portfolio data management, and transition services. FactSet's competitors include Bloomberg L.P., Refinitiv, and S&P Global. The company was founded in 1978 and is headquartered in Norwalk, CT.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine FDS's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
B
Safety
B
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Financial Datum & Stock Exchange

Industry Rating
B
FDS
Ranked
#7 of 12

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$325.02B
$539.69B
$10.64C
View Top Financial Datum & Stock Exchange Stocks

Be the first to know about important FDS news, forecast changes, insider trades & much more!

FDS News

Overview

Due Diligence Score

–
Industry Average (39)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FDS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FDS ($456.09) is trading above its intrinsic value of $135.08, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FDS is good value based on its earnings relative to its share price (32.23x), compared to the US market average (37.92x)
P/E vs Market Valuation
FDS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more FDS due diligence checks available for Premium users.

Valuation

FDS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
32.23x
Industry
36.75x
Market
37.92x
FDS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FDS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

FDS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
8.71x
Industry
5.32x
FDS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

FDS price to earnings growth (PEG)

For valuing profitable companies with growth potential

FDS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

FDS's financial health

Profit margin

Revenue
$568.7M
Net Income
$150.0M
Profit Margin
26.4%
FDS's Earnings (EBIT) of $719.49M... subscribe to Premium to read more.
Interest Coverage Financials
FDS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.0B
Liabilities
$2.1B
Debt to equity
1.03
FDS's short-term assets ($750.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FDS's long-term liabilities ($1.52B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FDS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FDS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$86.4M
Investing
-$145.1M
Financing
-$70.1M
FDS's operating cash flow ($631.57M)... subscribe to Premium to read more.
Debt Coverage Financials

FDS vs Financial Datum & Stock Exchange Stocks

TickerZen RatingMarket Cap1d %P/EP/B
FDSC$17.35B-0.72%32.23x8.71x
MORNB$13.94B-1.15%42.65x8.90x
DNBC$4.70B-0.47%-133.00x1.41x
VALUC$323.59M-0.26%14.62x3.35x
MSCIC$44.47B+0.06%40.64x-47.30x

Factset Research Systems Stock FAQ

What is Factset Research Systems's quote symbol?

(NYSE: FDS) Factset Research Systems trades on the NYSE under the ticker symbol FDS. Factset Research Systems stock quotes can also be displayed as NYSE: FDS.

If you're new to stock investing, here's how to buy Factset Research Systems stock.

What is the 52 week high and low for Factset Research Systems (NYSE: FDS)?

(NYSE: FDS) Factset Research Systems's 52-week high was $499.87, and its 52-week low was $391.84. It is currently -8.76% from its 52-week high and 16.4% from its 52-week low.

How much is Factset Research Systems stock worth today?

(NYSE: FDS) Factset Research Systems currently has 38,030,046 outstanding shares. With Factset Research Systems stock trading at $456.09 per share, the total value of Factset Research Systems stock (market capitalization) is $17.35B.

Factset Research Systems stock was originally listed at a price of $6.83 in Dec 31, 1997. If you had invested in Factset Research Systems stock at $6.83, your return over the last 27 years would have been 6,574.81%, for an annualized return of 16.83% (not including any dividends or dividend reinvestments).

How much is Factset Research Systems's stock price per share?

(NYSE: FDS) Factset Research Systems stock price per share is $456.09 today (as of Feb 14, 2025).

What is Factset Research Systems's Market Cap?

(NYSE: FDS) Factset Research Systems's market cap is $17.35B, as of Feb 17, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Factset Research Systems's market cap is calculated by multiplying FDS's current stock price of $456.09 by FDS's total outstanding shares of 38,030,046.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.